In with the New: Trump Freezes Pending and Non-Issued Obama-Era Regulations
Client Alert | 1 min read | 01.23.17
On January 20, 2017, President Trump's Chief of Staff Reince Priebus issued a memorandum to the heads of the executive departments and agencies calling for a regulatory freeze pending review – a practice that is relatively routine for new incoming presidential administrations. Specifically, the memorandum prohibits agencies from sending any regulation to the Office of Federal Register (OFR) prior to review and approval; requires agencies to immediately withdraw unpublished regulations for review and approval; and mandates that agencies temporarily postpone the implementation of published, but not yet effective, regulations for 60 days. Regulations subject to statutory or judicial deadlines are excluded from the aforementioned actions, but agencies must timely identify them to the OMB Director. Agencies also may identify regulations they believe should not be subject to the aforementioned procedures, namely those affecting "critical health, safety, financial, or national security matters, or for some other reason."
Contacts
Insights
Client Alert | 3 min read | 05.23.25
Executive Order Seeks Most-Favored-Nation Drug Pricing and HHS Announces Price Targets
On May 12, 2025, President Trump issued an Executive Order titled "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients," which aims to reduce the costs of prescription drugs and biologics for American consumers and other payers. This Order revives a plan from President Trump’s first term and follows his April Executive Order, “Lowering Drug Prices by Once Again Putting Americans First,” which also sought to reduce drug prices. With drug prices in the United States nearly three times higher than many other countries, this second Order asks drug manufacturers to adopt Most-Favored-Nation (MFN) pricing for drugs sold in the United States or face potential regulation. MFN pricing would tether drug prices offered in the United States to the lower-cost prices offered in other comparably developed nations, such as Canada, Germany, or the United Kingdom.
Client Alert | 4 min read | 05.22.25
Opportunities for Procurement on the Horizon as UK Concludes Free Trade Agreement With India
Client Alert | 2 min read | 05.22.25
What Trump’s Nominee for IRS Commissioner Could Mean for Employee Retention Tax Credit Enforcement
Client Alert | 3 min read | 05.20.25
